摘要
目的观察醒脑静治疗脑梗死的疗效。方法96例入选的脑梗死患者随机分为2组。对照组48例病人给予常规治疗,观察组48例病人在常规治疗基础上应用醒脑静30mlivgttqd。结果两组间发病时间及神经功能缺陷无显著差异(P>0.05),治疗后30d,醒脑静治疗组神经功能缺损评分与对照组比较有统计学差异(P<0.05),观察组血液中的C-反应蛋白含量与对照组比较明显降低(P<0.05)。结论醒脑静能有效改善急性脑梗死的神经功能缺失,疗效好值得临床推广应用。
Objective To study the therapeutic effect of Xingnaojing in treatment of cerebral infarction. Methods Ninety - Six patients with cerebral infarction were randomly divided into two groups ： Xingnaojing group （ n = 48 ） and control group （ n = 48）. The neurological defect scoring system was used before and after treatment to evaluate the patients＇responses to Xingnaojing. C -reactive protein in blood was also evaluated. Results In Xingnaojing group, the neurological defect scoring was significantly improved as well （ P 〈 0.05 ）. C - reactive protein in blood was also significantly lower between the two groups （P 〈 0.05 ）. Conclusions Xingnaojing can reduce neurological deficit of acute cerebral infarction. Its clinical application is effective, convenient and worthy of clinical application.
出处
《医学信息（手术学分册）》
2008年第12期1092-1093,共2页
Medical Information Operations Sciences Fascicule
关键词
脑梗死
醒脑静
C-反应蛋白
cerebral infarction
Xingnaojing
C - reactive protein
